Roland Fasol
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Roland Fasol has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
M Deutsch
2 shared publicationsP Zilla
Department of Cardio-Thoracic Surgery, University of Cape Town Medical School, South Africa
2 shared publicationsB Krisch
1 shared publicationB. Pfannmüller
Herz- und Gefaess-Klinik, Bad Neustadt/Saale, Germany
1 shared publicationBettina Pfannmüller
1 shared publicationC Heidinger
1 shared publication
Latest Publications
- 30 June 2004
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 77 (6) , 1985-1988
Mitral valve repair with the Colvin-Galloway future band
- 30 June 2004
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 77 (6) , 1985-1988
Mitral valve repair with the Colvin-Galloway future band
- 1 January 2001
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 71 (1) , 381-383
Triangular resection of the anterior leaflet for repair of the mitral valve
- 1 January 2001
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 71 (1) , 381-383
Triangular resection of the anterior leaflet for repair of the mitral valve
- 1 September 2000
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 70 (3) , 771-777
Papillary muscle repair surgery in ischemic mitral valve patients
- 1 September 2000
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 70 (3) , 771-777
Papillary muscle repair surgery in ischemic mitral valve patients
- 1 August 2000
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 70 (2) , 653-654
Early failure of bioprosthesis by preserved mitral leaflets
- 1 August 2000
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 70 (2) , 653-654
Early failure of bioprosthesis by preserved mitral leaflets
- Open Access
- 1 November 1998
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 19 (11) , 1730-1734
Papillary muscle shortening for mitral valve reconstruction in patients with ischaemic mitral insufficiency
AimsTo evaluate the feasibility of papillary muscle shortening in a specific group of high risk patients with ischaemic mitral regurgitation undergoi
- 1 November 1998
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 19 (11) , 1730-1734
Open AccessPapillary muscle shortening for mitral valve reconstruction in patients with ischaemic mitral insufficiency
AimsTo evaluate the feasibility of papillary muscle shortening in a specific group of high risk patients with ischaemic mitral regurgitation undergoi
- 1 September 1994
- Vol. 116 (3) , 524-34
In vitro-lined endothelium: initial integrity and ultrastructural events.
The early fate of in vitro-endothelialized prosthetic vascular grafts was assessed in the nonhuman primate. Each of 17 male chacma baboons received a control and a confluently endothelialized 4 mm polytetrafluoroethylene graft in femoro-femoral positions (8.2 +/- 0.8 cm). All experimental grafts were precoated with fibrinolytically inhibited fibrin glue and lined with cultured autologous endothelial cells (EC) from the external jugular vein. The average time period needed to obtain first-passage mass-cultures sufficient for preconfluent graft endothelialization was 19.8 +/- 5.2 days. Before implantation in vitro-lined grafts were kept in culture for another 16.1 +/- 4.3 days to achieve complete confluence and maturation of the EC cytoskeleton. After 9 days of implantation, endothelial-lined grafts still showed a confluent endothelium that was free of any fibrin deposits. However, the EC density was significantly lower than at implantation (39.7 +/- 7.6 x 10(3) versus 59.9 +/- 8.5 x 10(3) EC/cm2; p < 0.05), and occasional 10-microns-wide intercellular gaps with adherent platelets and leukocytes were visible. Transmission electron microscopy showed leukocytes and cell debris in the underlying fibrin glue. After 4 weeks of implantation, the endothelium of experimental prostheses had regained a high cell density (72.7 +/- 10.5 x 10(3) EC/cm2) with a mature and well-differentiated morphologic appearance. At both observation periods, the surface of control grafts showed a wide range from fibrin deposits to an amorphous protein coverage containing spread platelets. The endothelium of in vitro-endothelialized vascular prostheses remains confluent after implantation and is nonthrombogenic in spite of a moderate initial cell loss.
- 1 September 1994
- Vol. 116 (3) , 524-34
In vitro-lined endothelium: initial integrity and ultrastructural events.
The early fate of in vitro-endothelialized prosthetic vascular grafts was assessed in the nonhuman primate. Each of 17 male chacma baboons received a control and a confluently endothelialized 4 mm polytetrafluoroethylene graft in femoro-femoral positions (8.2 +/- 0.8 cm). All experimental grafts were precoated with fibrinolytically inhibited fibrin glue and lined with cultured autologous endothelial cells (EC) from the external jugular vein. The average time period needed to obtain first-passage mass-cultures sufficient for preconfluent graft endothelialization was 19.8 +/- 5.2 days. Before implantation in vitro-lined grafts were kept in culture for another 16.1 +/- 4.3 days to achieve complete confluence and maturation of the EC cytoskeleton. After 9 days of implantation, endothelial-lined grafts still showed a confluent endothelium that was free of any fibrin deposits. However, the EC density was significantly lower than at implantation (39.7 +/- 7.6 x 10(3) versus 59.9 +/- 8.5 x 10(3) EC/cm2; p < 0.05), and occasional 10-microns-wide intercellular gaps with adherent platelets and leukocytes were visible. Transmission electron microscopy showed leukocytes and cell debris in the underlying fibrin glue. After 4 weeks of implantation, the endothelium of experimental prostheses had regained a high cell density (72.7 +/- 10.5 x 10(3) EC/cm2) with a mature and well-differentiated morphologic appearance. At both observation periods, the surface of control grafts showed a wide range from fibrin deposits to an amorphous protein coverage containing spread platelets. The endothelium of in vitro-endothelialized vascular prostheses remains confluent after implantation and is nonthrombogenic in spite of a moderate initial cell loss.
- 20 January 1989
- Vol. 101 (2) , 66-9
[Infrarenal aortic aneurysm: results of surgical treatment].
Between 1976 and 1987 93 patients with an infrarenal aortic aneurysm underwent surgical correction. In 62 patients the procedure was performed electively, whilst 13 displayed an unstable aneurysm and in 18 cases a ruptured aneurysm was present at operation. During the past 5 years the mortality was lowered to 2% in elective cases, whereas in cases of ongoing rupture only moderate improvement took place. The most frequent cause of a lethal outcome was pump failure of the heart (6 times), followed by renal insufficiency and haemorrhagic shock and bleeding complications. Among the non-lethal complications, relaparotomy on the basis of postoperative bleeding ranks first, followed by pulmonary insufficiency, peripheral emboli and partial ischemia of the spine. Resection of infrarenal aneurysms should be performed in the stable state of disease, since insufficiency of multiple vital organ systems increases the mortality by up to 20 fold.
- 20 January 1989
- Vol. 101 (2) , 66-9
[Infrarenal aortic aneurysm: results of surgical treatment].
Between 1976 and 1987 93 patients with an infrarenal aortic aneurysm underwent surgical correction. In 62 patients the procedure was performed electively, whilst 13 displayed an unstable aneurysm and in 18 cases a ruptured aneurysm was present at operation. During the past 5 years the mortality was lowered to 2% in elective cases, whereas in cases of ongoing rupture only moderate improvement took place. The most frequent cause of a lethal outcome was pump failure of the heart (6 times), followed by renal insufficiency and haemorrhagic shock and bleeding complications. Among the non-lethal complications, relaparotomy on the basis of postoperative bleeding ranks first, followed by pulmonary insufficiency, peripheral emboli and partial ischemia of the spine. Resection of infrarenal aneurysms should be performed in the stable state of disease, since insufficiency of multiple vital organ systems increases the mortality by up to 20 fold.
- 1 November 1987
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 35 (S 2) , 143-147
In Vitro Lining of Fibronectin coated PTFE Grafts with Cryopreserved Saphenous Vein Endothelial Cells
In an attempt to produce instant endothelial cell (EC) monolayers on graft surfaces, cryopreserved cultivated human saphenous vein endothelial cells (HSVEC) were cultivated on reinforced PTFE prostheses. The graft surface was precoated with 40 μg/ml human fibronectin (HFN) prior to seeding with 200 × 103 EC/cm2. The seeding procedure was performed in a specially designed rotation device. After a cultivation period of 9 days, the seeded endothelial cells on the PTFE prostheses were exposed to shear stresses in a perfusion circuit, containing a bubble oxygenator, a roller pump and a tygon perfusion loop. The applied shear forces were 3 and 6dyn/cm2, respectively. In control grafts, spontaneous cell detachment occurred from day 11 onwards and only 50% of the graft surface remained endothelialized on day 16. When the grafts were exposed to 3dyn/cm2 only small cell-free areas less than 1000 urn in diameter were found after 4 hours of perfusion. In contrast, exposure to 6dyn/cm2 produced discouraging results: as early as 4 hours after the onset of perfusion 50% of the graft surface was cell free. After 16 hours only 20% endothelial cell coverage was seen under the stereo microscope. However, assuming that an ideal precoating substratum can be found, the two stage technique of in vitro endothelialization of vascular grafts with autologous endothelial cells may offer a promising clinical method. Moreover, the fact that our grafts were lined with cryopreserved EC implies the possible prospect of cell banks supplying unlimited numbers of EC for subsequent bypass operations. In einem Versuch, eine einschichtige Auskleidung von Kunststoffgrafts mit Endothelzellen (EC) zu erzielen, wurden cryokonservierte menschliche V. saphena-Endothelzellen auf verstarkten PTFE-Prothesen kultiviert. Vor der Aussaat von 200 × 103 EC/cm2 wurde die Prothesenoberfläche mit 40 μg/ml menschlichem Fibronectin beschichtet. Die Aussaat erfolgte mittels eines eigens konstruierten Rotationsgerätes. Nach einer Kultivierungszeit von 9 Tagen wurden die auf der PTFE-Prothese ausgesäten EC Scherkräften ausgesetzt, und zwar mit Hilfe eines Perfusionssystems, das einen Bubble-Oxygenator, eine Rollerpumpe und ein Tygon-Schlauchsystem enthielt. Die angewendeten Scherkräfte betrugen 3 und 6 dyn/cm2. In Kontrollprothesen fand vom 11. Tag an eine spontane Zellablösung statt. Am 16. Tag waren nur noch 50% der Prothesenoberfläche endothelialisiert. Wenn die Prothesen einer Wirkung von 3 dyn/cm2 ausgesetzt waren, fanden sich nach 4stündiger Perfusion nur kleine zellfreie Areale von wenigerals 1000 μm im Durchmesser. Dagegen führte die Anwendung von 6 dyn/cm2 zuentmutigenden Resultaten: bereits 4 Stunden nach Einsetzen der Perfusion waren 50% der Prothesenoberfläche zellfrei. Nach 16 Stunden waren nur noch 20% der Endothelzellschicht unterdem Mikroskopsichtbar. Unterder Annahme, daß sich ein ideales Beschichtungssubstrat finden läßt, kann die zweizeitige Operationstechnik der In-vitro-Endothelialisierung der Gefäßprothesen mit autologen Endothelzellen eine vielversprechende klinische Methode werden. Die Auskleidung unserer Prothesen mit cryokonservierten EC impliziert möglicherweise die Aussicht auf Zellbanken zur Herstellung einer unbegrenzten Anzahl von EC für vorgesehene Bypassoperationen.
- 1 November 1987
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 35 (S 2) , 143-147
In Vitro Lining of Fibronectin coated PTFE Grafts with Cryopreserved Saphenous Vein Endothelial Cells
In an attempt to produce instant endothelial cell (EC) monolayers on graft surfaces, cryopreserved cultivated human saphenous vein endothelial cells (HSVEC) were cultivated on reinforced PTFE prostheses. The graft surface was precoated with 40 μg/ml human fibronectin (HFN) prior to seeding with 200 × 103 EC/cm2. The seeding procedure was performed in a specially designed rotation device. After a cultivation period of 9 days, the seeded endothelial cells on the PTFE prostheses were exposed to shear stresses in a perfusion circuit, containing a bubble oxygenator, a roller pump and a tygon perfusion loop. The applied shear forces were 3 and 6dyn/cm2, respectively. In control grafts, spontaneous cell detachment occurred from day 11 onwards and only 50% of the graft surface remained endothelialized on day 16. When the grafts were exposed to 3dyn/cm2 only small cell-free areas less than 1000 urn in diameter were found after 4 hours of perfusion. In contrast, exposure to 6dyn/cm2 produced discouraging results: as early as 4 hours after the onset of perfusion 50% of the graft surface was cell free. After 16 hours only 20% endothelial cell coverage was seen under the stereo microscope. However, assuming that an ideal precoating substratum can be found, the two stage technique of in vitro endothelialization of vascular grafts with autologous endothelial cells may offer a promising clinical method. Moreover, the fact that our grafts were lined with cryopreserved EC implies the possible prospect of cell banks supplying unlimited numbers of EC for subsequent bypass operations. In einem Versuch, eine einschichtige Auskleidung von Kunststoffgrafts mit Endothelzellen (EC) zu erzielen, wurden cryokonservierte menschliche V. saphena-Endothelzellen auf verstarkten PTFE-Prothesen kultiviert. Vor der Aussaat von 200 × 103 EC/cm2 wurde die Prothesenoberfläche mit 40 μg/ml menschlichem Fibronectin beschichtet. Die Aussaat erfolgte mittels eines eigens konstruierten Rotationsgerätes. Nach einer Kultivierungszeit von 9 Tagen wurden die auf der PTFE-Prothese ausgesäten EC Scherkräften ausgesetzt, und zwar mit Hilfe eines Perfusionssystems, das einen Bubble-Oxygenator, eine Rollerpumpe und ein Tygon-Schlauchsystem enthielt. Die angewendeten Scherkräfte betrugen 3 und 6 dyn/cm2. In Kontrollprothesen fand vom 11. Tag an eine spontane Zellablösung statt. Am 16. Tag waren nur noch 50% der Prothesenoberfläche endothelialisiert. Wenn die Prothesen einer Wirkung von 3 dyn/cm2 ausgesetzt waren, fanden sich nach 4stündiger Perfusion nur kleine zellfreie Areale von wenigerals 1000 μm im Durchmesser. Dagegen führte die Anwendung von 6 dyn/cm2 zuentmutigenden Resultaten: bereits 4 Stunden nach Einsetzen der Perfusion waren 50% der Prothesenoberfläche zellfrei. Nach 16 Stunden waren nur noch 20% der Endothelzellschicht unterdem Mikroskopsichtbar. Unterder Annahme, daß sich ein ideales Beschichtungssubstrat finden läßt, kann die zweizeitige Operationstechnik der In-vitro-Endothelialisierung der Gefäßprothesen mit autologen Endothelzellen eine vielversprechende klinische Methode werden. Die Auskleidung unserer Prothesen mit cryokonservierten EC impliziert möglicherweise die Aussicht auf Zellbanken zur Herstellung einer unbegrenzten Anzahl von EC für vorgesehene Bypassoperationen.